Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
A. Keys.
Coronary heart disease in Seven Countries.
Circulation, 41 (1974), pp. 1-211
[2.]
S.M. Grundy, M.A. Denke.
Dietary influences on serum lipids and lipoproteins.
J Lipid Res, 31 (1990), pp. 1149-1172
[3.]
E.J. Schaefer.
Lipoproteins, nutrition, and heart disease.
Am J Clin Nutr, 75 (2002), pp. 191-212
[4.]
M.A. Rubio, J.A. Gutiérrez Fuentes, J.A. Gómez Gerique, M.D. Ballesteros, M.T. Montoya, por el grupo DRECE.
Estudio DRECE: dieta y riesgo de enfermedades cardiovasculares en España. Hábitos nutricionales en la población española.
Endocr Nutr, 47 (2000), pp. 294-300
[5.]
M. Denke, S.M. Grundy.
Comparison of effects of lauric acid and palmitic acid on plasma lipids and lipoproteins.
Am J Clin Nutr, 56 (1992), pp. 895-898
[6.]
R.P. Mensink.
Effects of individual saturated fatty acids on serum lipid and lipoprotein concentration.
Am J Clin Nutr, 57 (1993), pp. 1115-1145
[7.]
P.L. Zock, J.H.M. De Vries, M.B. Katan.
Impact of miristic acid versus palmitic acid on serum lipid and lipoprotein levels in healthy women and men.
Arterioscler Thromb, 14 (1994), pp. 567-575
[8.]
R.P. Mensink, M.B. Katan.
Effects of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis of 27 trials.
Arterioescler Thromb, 12 (1991), pp. 911-919
[9.]
A. Bonanome, S.M. Grundy.
Effect of dietary stearic acid on plasma cholesterol and lipoprotein levels.
N Engl J Med, 318 (1988), pp. 1244-1248
[10.]
S. Yu, J. Derr, T.D. Etherton, P.M. Kris-Etherton.
Plasma cholesterol-predictive equations demonstrate that stearic acid is neutral and monounsaturated fatty acids are hypocholesterolemic.
Am J Clin Nutr, 61 (1995), pp. 1129-1139
[11.]
T.A.B. Sanders, F.R. Oakley, J.A. Cooper, G.J. Miller.
Influence of a stearic acid-rich structured triacylglycerol on postprandial lipemia, factor VII concentrations, and fibrinolytic activity in healthy subjects.
Am J Clin Nutr, 73 (2001), pp. 715-721
[12.]
J.E. Hunter, J. Zhang, P.M. Kris-Etherton.
Cardiovascular disease risk of dietary stearic acid compared with trans and other saturated, and unsaturated fatty acids: a systematic review.
Am J Clin Nutr, 91 (2010), pp. 46-63
[13.]
S.W. Siri-Tarino, Q. Sun, F. Hu, R.M. Krauss.
Meta-analysis of prospective-cohort studies evaluating the association of saturated fat with cardiovascular disease.
Am J Clin Nutr, 91 (2010), pp. 535-546
[14.]
S.W. Siri-Tarino, Q. Sun, F. Hu, R.M. Krauss.
Saturated fat, carbohydrates, and cardiovascular disease.
Am J Clin Nutr, 91 (2010), pp. 502-509
[15.]
J. Stamler.
Diet-Heart: a problematic revisit.
Am J Clin Nutr, 91 (2010), pp. 497-499
[16.]
R.P. Mensink, M.B. Katan.
Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects.
N Engl J Med, 323 (1990), pp. 439-445
[17.]
R.P. Mensink.
Metabolic and health effects of isomeric fatty acids.
Curr Opin Lipidol, 16 (2005), pp. 27-30
[18.]
D. Mozzaffarian, A. Aro, W.C. Willett.
Health effects of trans-fatty acids: experimental and observational evidence.
Eur J Clin Nutr, 63 (2009), pp. S5-S21
[19.]
A. Ascherio, C.H. Hennekens, J.E. Buring, C. Master, M.J. Stampfer, W.C. Willett.
Trans-fatty acids intake and risk of myocardial infarction.
Circulation, 89 (1994), pp. 94-101
[20.]
A. Aro, A.F. Kardinaal, I. Salminen, J.D. Kark, R.A. Riemersma, M. Delgado-Rodríguez, et al.
Adipose tissue isomeric trans fatty acids and risk of myocardial infarction in nine countries: the EURAMIC study.
Lancet, 345 (1995), pp. 273-278
[21.]
F.B. Hu, M.J. Stampfer, J.E. Manson, E. Rimm, G.A. Colditz, B.A. Rosner, et al.
Dietary fat intake and the risk of coronary heart disease in women.
N Engl J Med, 337 (1997), pp. 1491-1499
[22.]
J. Salmeron, F.B. Hu, J.E. Manson, M.J. Stampfer, G.A. Colditz, E.B. Rimm, et al.
Dietary fat intake and risk of type 2 diabetes in women.
Am J Clin Nutr, 73 (2001), pp. 1019-1026
[23.]
S.Y. Angell, L.D. Silver, G.P. Goldstein, C.M. Johnson, D.R. Deitchter, T.R. Frieden, et al.
Cholesterol control beyond the clinic: New York city's trans fat restriction.
Ann Intern Med, 151 (2009), pp. 129-134
[24.]
M.R. L’Abbé, S. Stender, M. Skeaff, Ghafoorunissa, M. Tavella.
Approaches to mevoming trans fats from the food supply in industrialized and developing countries.
Eur J Clin Nutr, 63 (2009), pp. S50-S67
[25.]
H.N. Ginsberg, S.L. Barr, A. Gilbert, W. Karmally, R. Deckelbaum, K. Kaplan, et al.
Reduction of plasma cholesterol levels in men on an American Heart Association step 1 diet with added monounsaturated fat.
N Engl J Med, 322 (1990), pp. 574-579
[26.]
F.H. Mattson, S.M. Grundy.
Comparison of effects of dietary saturated, monounsaturated and polyunsaturated fatty acids on plasma lipids and lipoproteins in man.
J Lipid Res, 26 (1985), pp. 194-202
[27.]
E.M. Berry, S. Eisenberg, D. Haratz, Y. Frielander, Y. Norman, N.A. Kaufmann, et al.
Effects of diet rich in monounsaturated fatty acids on plasma lipoproteins -the Jerusalem Nutrition study: high MUFAs vs high PUFAs.
Am J Clin Nutr, 53 (1991), pp. 899-907
[28.]
E.M. Berry, S. Eisenberg, Y. Friedlander, D. Harats, N.A. Kaufmann, Y. Norman, et al.
Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins -the Jerusalem Study. II Monounsaturated fatty acids vs carbohydrates.
Am J Clin Nutr, 56 (1992), pp. 394-402
[29.]
M. Fitó, M.I. Covas, R.M. Lamuela-Raventós, J. Vila, C. De la Torre, J. Marrugat.
Aceite de oliva e inhibición de la oxidación de las lipoproteínas de baja densidad. Importancia de los compuestos fenólicos.
Med Clin (Barc), 115 (2000), pp. 166-169
[30.]
M. Fitó, M.I. Covas, R.M. Lamuela-Raventós, J. Vila, C. De la Torre, J. Marrugat.
Protective effect of olive oil and its phenolic compounds against low density lipoprotein oxidation.
Lipids, 35 (2000), pp. 633-638
[31.]
M. Brenes, A. García, P. García, J.J. Ríos, A. Garrido.
Phenolic compounds in spanish olive Oil.
J Agric Food Chem, 47 (1999), pp. 3535-3540
[32.]
F. Pérez-Jiménez, J. Ruano, P. Pérez-Martínez, F. López-Segura, J. López-Miranda.
The influence of olive oil on human health: not a question of fat alone.
Mol Nutr Food Res, 51 (2007), pp. 1199-1208
[33.]
J.S. Kwon, J.T. Snook, G.M. Wardlaw, D.H. Hwang.
Effects of diets high in saturated fatty acids, canola oil, or safflower oil on platelet function, thromboxane B2 formation, and fatty acid composition of platelet phospholipids.
Am J Clin Nutr, 54 (1991), pp. 351-358
[34.]
F. López Segura, F. Velasco, J. López Miranda, P. Castro, R. López Pedrera, A. Blanco, et al.
Monounsaturated fatty acid-enriched diet decreases plasma plasminogen activator inhibitor type 1.
Arterioscler Thromb Vasc Biol, 16 (1996), pp. 82-88
[35.]
P. Mata, R. Alonso, A. López Farré, J.M. Ordovás, C. Lahoz, C. Garcés, et al.
Effects of dietary fat saturation on LDL oxidation and monocyte adhesion to human endothelial cells in vitro.
Artheroscler Thromb Vasc Biol, 16 (1996), pp. 1347-1355
[36.]
F. Fuentes, J. López-Miranda, E. Sánchez, F. Sánchez, J. Páez, Paz-Rojas, et al.
Mediterranean and low-fat diets improve endothelial function in hypercholesterolemic men.
Ann Intern Med, 134 (2001), pp. 1115-1119
[37.]
V.M. Rodríguez, M.P. Portillo, C. Picó, M.T. Macarulla, A. Palou.
Olive oil feeding up-regulates uncoupling protein genes in rat brown adipose tissue and skeletal muscle.
Am J Clin Nutr, 75 (2002), pp. 213-220
[38.]
C. Bellido, J. López-Miranda, L. Miguel Blanco-Colio, P. Pérez-Martínez, F.J. Muriana, J.L. Martín-Ventura, et al.
Butter and walnuts, but not olive oil, elicit postprandial activation of nuclear transcription factor κB in peripheral blood mononuclear cells from healthy men.
Am J Clin Nutr, 80 (2004), pp. 1487-1491
[39.]
J.A. Paniagua, A. Gallego de la Sacristana, E. Sánchez, I. Romero, A. Vidal-Puig, F.J. Berra, et al.
A MUFA-Rich Diet Improves Posprandial Glucose, Lipid and GLP-1 Responses in Insulin-Resistant Subjects.
J Am Coll Nutr, 26 (2007), pp. 434-444
[40.]
A.T. Lada, L.L. Rudel.
Dietary monounsaturated versus polyunsaturated fatty acids: which is really better for protection from coronary heart disease?.
Curr Opin Lipidol, 14 (2003), pp. 41-46
[41.]
M. De Lorgeril, P. Salen, J.L. Martin, I. Monjaud, J. Delaye, N. Mamelle.
Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study.
Circulation, 99 (1999), pp. 779-785
[42.]
G.E. Fraser, J. Sabaté, W.L. Beeson, T.M. Strahan.
A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study.
Arch Intern Med, 152 (1992), pp. 1416-1424
[43.]
E. Ros, I. Núñez, A. Pérez-Heras, M. Serra, R. Gilabert, E. Casals, et al.
A walnut diet improves endothelial function in hypercholesterolemic subjects. A randomized crossover trial.
Circulation, 109 (2004), pp. 1609-1614
[44.]
W.E. Connor.
Importance of n-3 fatty acids in health and disease.
Am J Clin Nutr, 71 (2000), pp. 171S-175S
[45.]
E. Guallar, F.J. Jiménez, M. Tafalla, J.M. Martín Moreno.
Consumo de pescado y mortalidad coronaria en población general: metaanálisis de estudios de cohorte.
Gac Sanit, 7 (1993), pp. 228-236
[46.]
E. Guallar, C.H. Hennekens, F.M. Sacks, W.C. Willett, M.J. Stampfer.
A prospective study of plasma fish oil levels and incidence of myocardial infarction in US male physicians.
J Am Coll Cardiol, 25 (1995), pp. 387-394
[47.]
C. Wang, W.S. Harris, M. Chung, A.H. Lichtenstein, E.M. Balk, B. Kupelnick, et al.
n3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review.
Am J Clin Nutr, 84 (2006), pp. 5-17
[48.]
J.K. Virtanen, D. Mozaffarian, S.E. Chiuve, E.B. Rimm.
Fish consumption and risk of major chronic disease in men.
Am J Clin Nutr, 88 (2008), pp. 1618-1625
[49.]
M.L. Burr, J.F. Gilbert, R.M. Holliday, P.C. Elwood, A.M. Fehily, S. Rogers, et al.
Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).
Lancet, 2 (1989), pp. 757-761
[50.]
C.M. Albert, C.H. Hennekens, C.J. O’Donnell, U.A. Ajani, V.J. Carey, W.C. Willet, et al.
Fish consumption and risk of sudden cardiac death.
JAMA, 279 (1998), pp. 23-28
[51.]
Gruppo Italiano per lo studio della sopravvivenza nell’infarto miocardico.
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial.
Lancet, 354 (1999), pp. 447-455
[52.]
B. London, C. Albert, M.E. Anderson, W.R. Giles, D.R. Van Wagoner, E. Balk, et al.
Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and Their Role in Cardiac Arrhythmogenesis Workshop.
Circulation, 116 (2007), pp. e320-e335
[53.]
E. Guallar, I. Sanz-Gallardo, P. Van’t Veer, P. Bode, A. Aro, J. Gómez-Aracena, et al.
Mercury, fish oils, and the risk of myocardial infarction.
N Engl J Med, 347 (2002), pp. 1747-1754
[54.]
D. Mozzafarian.
Fish, mercury, selenium and cardiovascular risk: current evidence and unanswered questions.
Int J Environ Res Public Health, 6 (2009), pp. 1894-1916
[55.]
T. Hampton.
Farmed, wild salmon pollutans probed.
JAMA, 291 (2004), pp. 929-930
[56.]
P.M. Kris-Etherton, W.S. Harris, L.J. Appel, For the Nutrition Committee.
AHA Scientific Statement. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.
Arterioscler Thromb Vasc Biol, 23 (2003), pp. e20-e31
[57.]
E. Ros.
El colesterol de la dieta y su escasa influencia sobre la colesterolemia y el riesgo cardiovascular.
Clin Invest Arterioscler, 12 (2000), pp. 20-26
[58.]
H.N. Ginsberg, W. Karmally, M. Siddiqui, S. Holleran, A.R. Tall, W.S. Blaner, et al.
Increases in dietary cholesterol are associated with modest increases in both LDL and HDL cholesterol in healthy young women.
Arterioscler Thromb Vasc Biol, 15 (1995), pp. 169-178
[59.]
P. Hopkins.
Effects of dietary cholesterol on serum cholesterol: a meta-analysis and review.
Am J Clin Nutr, 324 (1992), pp. 896-899
[60.]
J. Plat, D. Kerckhoffs, R.P. Mensink.
Therapeutical potential of plant sterols and stanols.
Curr Opin Lipidol, 11 (2000), pp. 571-576
[62.]
H. Gylling, P. Puska, E. Vartiainen, T.A. Miettinen.
Retinol, vitamin D, carotene and alfa-tocopherol in serum of a moderately hypercholesterolemic population consuming sitostanol ester margarine.
Atherosclerosis, 145 (1999), pp. 279-285
[63.]
K.G. Gey.
Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology.
Am J Clin Nutr, 53 (1991), pp. 326S-334S
[64.]
A.FM. Kaardinal.
Antioxidants in adiposse tissue and risk of myocardial infarction: the EURAMIC study.
Lancet, 342 (1993), pp. 1279-1284
[65.]
P. Knekt, J. Ritz, M.A. Pereira, E.J. O’Reilly, K. Augustsson, G.E. Fraser, et al.
Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts.
Am J Clin Nutr, 80 (2004), pp. 1508-1520
[66.]
G.S. Omenn, G.E. Goodman, M.D. Thornquist, J. Balmes, M.R. Cullen, A. Glass, et al.
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease.
N Engl J Med, 334 (1996), pp. 1150-1155
[67.]
The Alpha tocopherol, Beta Carotene Cancer Prevention Study Group.
The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers.
N Engl J Med, 330 (1994), pp. 1029-1035
[68.]
N.G. Stephens, A. Parsons, P.M. Schofield, F. Kelly, K. Cheeseman, M.J. Mitchinson.
Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS).
Lancet, 347 (1996), pp. 781-786
[69.]
GISSI-Prevenzione Investigators (Grupo Italiano per lo Studio della Sopravivenza nell Infato Miocárdico).
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial.
Lancet, 354 (1999), pp. 447-455
[70.]
E.R. Miller III, R. Pastor-Barriuso, D. Dalal, R.A. Rimersma, L.J. Appel, E. Guallar.
Meta-analysis: high dose vitamin E supplementation may increase all-cause mortality.
Ann Intern Med, 142 (2005), pp. 37-46
[71.]
G. Bjelakovic, D. Nikolova, L.L. Gluud, R.G. Simonetti, C. Gluud.
Mortality in randomized trials of antioxidant supplements for primary and secondary prevention. Systematic review and meta-analysis.
JAMA, 297 (2007), pp. 842-857
[72.]
M.G. Hertog, E.J. Feskens, P.C. Hollman, M.B. Katan, D. Kromhout.
Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly study.
Lancet, 342 (1993), pp. 1007-1011
[73.]
S.O. Keli, M.G. Hertog, E.J. Feskens, D. Kromhout.
Dietary flavonoids, antioxidant vitamins and incidence of stroke: the Zutphen Elderly Study.
Arch Intern Med, 154 (1996), pp. 637-642
[74.]
M.G.L. Hertog, D. Kromhout, C. Aravanis.
Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study.
Arch Intern Med, 155 (1995), pp. 381-386
[75.]
E.B. Rimm, M.B. Katan, A. Ascherio, M.J. Stampfer, W.C. Willet.
Relation between intake of flavonoids and risk of coronary heart disease in male Health Professionals.
Ann Intern Med, 125 (1996), pp. 384-389
[76.]
J.W. Anderson, B.M. Johnstone, M.E. Cook-Newell.
Meta-analysis of the effect of soy protein intake on serum lipids.
N Engl J Med, 333 (1995), pp. 276-282
[77.]
K. Taku, K. Umegaki, Y. Sato, Y. Taki, K. Endoh, S. Watanabe.
Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials.
Am J Clin Nutr, 85 (2007), pp. 1148-1156
[78.]
M.J. Tikkanen, K. Wahala, S. Ojala, V. Vihma, H. Adlercreutz.
Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance.
Proc Natl Aca Sci USA, 95 (1998), pp. 3106-3110
[79.]
L. Brown, B. Rosner, W.C. Willet, F.M. Sacks.
Cholesterol-lowering effects of dietary fiber: a meta-analysis.
Am J Clin Nutr, 69 (1999), pp. 30-42
[80.]
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult treatment Panel III). JAMA. 2001;285:2486-97.
[81.]
F. Sofi, F. Cesari, R. Abbate, G.F. Gensini, A. Casini.
Adherence to Mediterranean diet and health status: meta-analysis.
BMJ, 337 (2008), pp. a1344
[82.]
R. Estruch, M.A. Martínez-González, D. Corella, J. Salas-Salvadó, V. Ruiz-Gutiérrez, M.I. Covas, et al.
Effects of a Mediterraneanstyle diet on cardiovascular risk factors: a randomized trial.
Ann Intern Med, 145 (2006), pp. 1-11
[83.]
M. Fitó, M. Guxens, D. Corella, G. Sáez, R. Estruch, R. De la Torre, et al.
Effect of a traditional Mediterranean diet on lipoprotein oxidation: a randomized controlled trial.
Arch Intern Med, 167 (2007), pp. 1195-1203
[84.]
J. Salas-Salvadó, A. García-Arellano, R. Estruch, F. Márquez-Sandoval, D. Corella, M. Fiol, et al.
Components of the Mediterranean-type food pattern and serum inflammatory markers among patients at high risk for cardiovascular disease.
Eur J Clin Nutr, 62 (2008), pp. 651-659
[85.]
A. Sánchez-Taínta, R. Estruch, M. Bulló, D. Corella, E. Gómez-Gracia, M. Fiol, et al.
Adherence to a Mediterranean-type diet and reduced prevalence of clustered cardiovascular risk factors in a cohort of 3,204 high-risk patients.
Eur J Cardiovasc Prev Rehabil, 15 (2008), pp. 589-593
Copyright © 2010. Sociedad Española de Arteriosclerosis y Elsevier España S.L.